Dr. Eric Giza, MD

Dr. Giza practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Giza's NPI, 1811987571, was assigned on October 25, 2005. Dr. Giza graduated from Lewis Katz School of Medicine in 1998. Dr. Giza holds California license A86534.

Dr. Giza's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Giza's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Giza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giza practices, 2 sites in all. Vendor and product names are available with a free account.

Foot and ankle surgery is Dr. Giza's primary specialty in the NPI Registry, under taxonomy code 207XX0004X. Dr. Giza is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Giza's licenses on file in 3 states: California, Maine and Massachusetts.

Dmand AI lists ankle replacement, arthritis, broken or dislocated ankle/ or foot, enthesopathy in foot or ankle, joint cyst, joint pain, knee injury and leg, ankle or foot fracture among the conditions Dr. Giza treats.

CMS data shows 701 Medicare services from Dr. Giza across 19 procedure codes in 2024, for 322 Medicare patients. Medicare paid $74,041 for them.

CMS counts 322 Medicare patients who saw Dr. Giza in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have arthritis, and 70% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Giza's median patient age at 55, with 62% women.

In 2024, Dr. Giza wrote 25 Medicare Part D claims for 17 patients. 100% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $65 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Giza for performance year 2024, reported as part of a group. Dr. Giza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Giza as offering telehealth. CMS counts 11 procedures of lower limb (leg) arthroscopy (minimally invasive joint repair) by Dr. Giza, more than 81% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 74 papers to Dr. Giza, published from 2010 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Ankle Injuries, Cartilage, Articular and Arthroscopy. Dr. Giza has published most often in Foot Ankle Int. Dr. Giza's most frequent co-authors are Christopher D. Kreulen, MD, Connor Mitchell Delman and Lew C. Schon, MD.

CMS Open Payments shows 1,833 general payments to Dr. Giza from 61 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 57% of the total. Arthrex, Inc. paid the most, $3,939,173. It also lists 4 research payments totaling $46,878 from 2019 to 2021.

Dmand AI lists 1 award for Dr. Giza, most recently CMS Stage 1 EHR in 2012.

Dr. Giza graduated from Lewis Katz School of Medicine in 1998.

Dr. Giza is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.